If you have high risk prostate cancer, you may be able to participate in a research study to find out decreasing or increasing your radiation and hormonal therapy has an effect on your cancer.

Have you been diagnosed with high-risk early triple-negative breast cancer (TNBC) without mutations in the BRCA1 or BRCA2 gene? If you still have evidence of TNBC in your breast of lymph node tissue after receiving treatment and surgery, you may qualify for this clinical research study. This study will test an experimental drug combination to find out which treatment is better at delaying the return of cancer.

Do you have Stage 4 lung cancer or lung cancer that has come back? Have you previously been treated with chemotherapy and/or immunotherapy? You may be able to take part in a clinical research study to find out if treatment with two study drugs is more effective compared to usual treatments. No additional labs, testing, or questionnaires are required.

Do you have a history of ER+/HER2- breast cancer? Have you completed surgery and been on hormonal therapy for at least 2 years? If you have an increased risk of your cancer returning in the future, you may be able to take part in this clinical trial to help us learn if a new oral "SERD" therapy will further reduce the chance of recurrence.